Komori
The Hyakujushi Bank (8386) · RiskMitigated

Decline in valuation gains on securities and impairment losses

First written in FY2017-Q1. 14 of 35 entries say "Mitigated", first in FY2017-Q3. Latest entry: FY2026.

35entries
11years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseMitigatedFY2018-Q1 – FY2019-Q2MitigatedFY2025-H1 – FY2026-H12016: 220162017: 420172018: 420182019: 420192020: 320202021: 420212022: 420222023: 420232024: 320242025: 120252026: 22026
Same theme, other companies
Recognition of Valuation Losses on Investment Securities and Impairment LossesA theme 284 companies write about · 287 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2026: 35 of 80 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 198 companies compared. The sentences above are computed from all 198.Comparing 200 of the theme's 287 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026MitigatedAnnual report

    「The valuation difference on “other securities” was ¥95.834 billion in the current consolidated fiscal year, up from ¥51.841 billion in the previous consolidated fiscal year. No impairment losses were recorded in either fiscal year.」

    The valuation difference on other securities increased, and no securities impairment losses were recorded during the current fiscal year.
  2. 2026-05-12MaterialisedEarnings

    「Write-offs of stocks and other securities 1 1 －」

    Write-offs of stocks and other securities of ¥1 million were recorded for the consolidated fiscal year under review.
  3. FY2026-H1MitigatedAnnual report

    「At the end of the interim consolidated accounting period, the net valuation gain on “other securities” was ¥80.8 billion, an increase of ¥29.0 billion from the end of the previous consolidated fiscal year.」

    Valuation gains on other securities increased from the previous fiscal year-end, and no securities impairment losses were recorded during the current interim consolidated accounting period.
  4. FY2025-H1MitigatedAnnual report

    「Impairment losses in the previous consolidated fiscal year were ¥581 million, all on equities. No impairment losses were recorded during the current interim consolidated accounting period.」

    Compared with securities impairment losses of ¥581 million in the previous fiscal year, no impairment losses were recorded during the current interim period. The valuation difference on other securities increased.
  5. FY2024MaterialisedAnnual report

    「Impairment losses during the current consolidated fiscal year were ¥581 million, all on equities.」

    The valuation difference on other securities increased, while impairment losses of ¥581 million were recorded on equities.
  6. FY2024-Q3MaterialisedAnnual report

    「Impairment losses during the cumulative third quarter were ¥529 million, all on equities.」

    Valuation gains on other securities increased by ¥26.9 billion from the previous fiscal year-end, while impairment losses of ¥529 million on equities were recorded during the cumulative third quarter.
  7. FY2024-Q2MaterialisedAnnual report

    「Impairment losses during the current interim consolidated accounting period were ¥476 million, all on equities.」

    Valuation gains on other securities increased from the previous fiscal year-end, while impairment losses of ¥476 million on equities were recorded during the current interim period.
  8. FY2024-Q1MitigatedAnnual report

    「The net valuation gain on “other securities” was ¥38.2 billion, an increase of ¥17.4 billion from the end of the previous consolidated fiscal year.」

    Valuation gains on other securities increased from ¥20.8 billion at the previous fiscal year-end to ¥38.2 billion.
  9. FY2023WorsenedAnnual report

    「At the end of the current consolidated fiscal year, the net valuation gain on “other securities” was ¥20.8 billion, a decrease of ¥16.1 billion from the end of the previous consolidated fiscal year.」

    Valuation gains on other securities declined from approximately ¥36.9 billion at the previous fiscal year-end to ¥20.8 billion. Meanwhile, securities impairment losses during the current fiscal year were zero.
  10. FY2023-Q3WorsenedAnnual report

    「At the end of the third quarter of the current consolidated fiscal year, the net valuation gain on “other securities” was ¥8.2 billion, a decrease of ¥28.8 billion from the end of the previous consolidated fiscal year.」

    Valuation gains on other securities declined significantly from approximately ¥37.0 billion at the previous fiscal year-end to ¥8.2 billion. Securities impairment losses during the cumulative third quarter were ¥32 million.
  11. FY2023-Q2WorsenedAnnual report

    「At the end of the second quarter of the current consolidated fiscal year, the net valuation gain on “other securities” was ¥14.4 billion, a decrease of ¥22.5 billion from the end of the previous consolidated fiscal year.」

    Valuation gains on other securities declined significantly from ¥36.9 billion at the previous fiscal year-end to ¥14.4 billion. Meanwhile, no securities impairment losses were recorded during the current interim consolidated accounting period.
  12. FY2023-Q1WorsenedAnnual report

    「The net valuation gain on “other securities” was ¥19.3 billion, a decrease of ¥17.6 billion from the end of the previous consolidated fiscal year.」

    Valuation gains on other securities declined by ¥17.6 billion from the previous fiscal year-end. The impairment loss in the first quarter was ¥0 million, and no new impairment losses were recorded.
  13. FY2022Decline in valuation gains; no impairment lossesAnnual report

    「At the end of the current consolidated fiscal year, the net valuation gain on “other securities” was ¥37.0 billion, a decrease of ¥23.9 billion from the end of the previous consolidated fiscal year.」

    Valuation gains on other securities declined from ¥60.9 billion to ¥37.0 billion. Meanwhile, no securities impairment losses were recorded during the current fiscal year.
  14. FY2022-Q3Decline in valuation gains; no impairment lossesAnnual report

    「At the end of the third quarter of the current consolidated fiscal year, the net valuation gain on “other securities” was ¥57.3 billion, a decrease of ¥3.6 billion from the end of the previous consolidated fiscal year. Impairment losses in the previous consolidated fiscal year were ¥7.065 billion, all on equities. No impairment losses were recorded during the cumulative third quarter.」

    Valuation gains on other securities declined from the previous fiscal year-end, but no impairment losses were recorded during the cumulative third quarter.
  15. FY2022-Q2MitigatedAnnual report

    「At the end of the second quarter of the current consolidated fiscal year, the net valuation gain on “other securities” was ¥62.9 billion, an increase of ¥1.9 billion from the end of the previous consolidated fiscal year. Impairment losses in the previous consolidated fiscal year were ¥7.065 billion, all on equities. No impairment losses were recorded during the current interim consolidated accounting period.」

    Valuation gains on other securities increased from the previous fiscal year-end, and no impairment losses were recorded during the current interim consolidated accounting period.
  16. FY2022-Q1MitigatedAnnual report

    「The net valuation gain on “other securities” was ¥63.2 billion, an increase of ¥2.2 billion from the end of the previous consolidated fiscal year. Impairment losses in the previous consolidated fiscal year were ¥7.065 billion, all on equities. No impairment losses were recorded during the cumulative first quarter of the current consolidated fiscal year.」

    Valuation gains increased by ¥2.2 billion from the previous fiscal year-end, and no impairment losses were recorded during the cumulative first quarter.
  17. FY2021MaterialisedAnnual report

    「At the end of the current consolidated fiscal year, the net valuation gain on “other securities” was ¥60.9 billion, an increase of ¥39.4 billion from the end of the previous consolidated fiscal year. Impairment losses during the current consolidated fiscal year were ¥7.065 billion, all on equities.」

    Valuation gains increased, while securities impairment losses of ¥7.065 billion, mainly on equities, were recorded.
  18. FY2021-Q3MaterialisedAnnual report

    「At the end of the third quarter of the current consolidated fiscal year, the net valuation gain on “other securities” was ¥57.9 billion, an increase of ¥36.3 billion from the end of the previous consolidated fiscal year. Impairment losses in the previous consolidated fiscal year were ¥1.948 billion, all on equities. Impairment losses during the cumulative third quarter were ¥8.803 billion, all on equities.」

    Valuation gains increased from the previous fiscal year-end, while impairment losses during the cumulative third quarter increased to ¥8.803 billion, mainly on equities.
  19. FY2021-Q2MaterialisedAnnual report

    「At the end of the second quarter of the current consolidated fiscal year, the net valuation gain on “other securities” was ¥50.8 billion, an increase of ¥29.3 billion from the end of the previous consolidated fiscal year. Impairment losses during the current interim consolidated accounting period were ¥8.663 billion, all on equities.」

    Valuation gains on other securities increased, while impairment losses of ¥8.663 billion were recorded on equities.
  20. FY2021-Q1MaterialisedAnnual report

    「The net valuation gain on “other securities” was ¥42.9 billion, an increase of ¥21.4 billion from the end of the previous consolidated fiscal year. Impairment losses during the cumulative first quarter were ¥7.525 billion, all on equities.」

    Valuation gains on other securities increased from the fiscal year-end, while impairment losses of ¥7.525 billion on equities were recorded during the cumulative first quarter.
  21. FY2020-Q3Decline in valuation gains; no impairment lossesAnnual report

    「At the end of the third quarter of the current consolidated fiscal year, the net valuation gain on “other securities” was ¥64.0 billion, a decrease of ¥4.4 billion from the end of the previous consolidated fiscal year.」

    Valuation gains on other securities declined from the previous fiscal year-end. Meanwhile, no impairment losses on securities were recorded during the cumulative third quarter.
  22. FY2020-Q2MitigatedAnnual report

    「At the end of the interim consolidated accounting period, the net valuation gain on “other securities” was ¥68.5 billion, an increase of ¥94 million from the end of the previous consolidated fiscal year. Impairment losses in the previous consolidated fiscal year were ¥293 million, all on equities. No impairment losses were recorded during the current interim consolidated accounting period.」

    Valuation gains on other securities increased slightly from the previous fiscal year-end, and no impairment losses were recorded during the current interim consolidated accounting period.
  23. FY2020-Q1Decline in valuation gains; no impairment losses during the quarterAnnual report

    「The net valuation gain on “other securities” was ¥66.2 billion, a decrease of ¥2.2 billion from the end of the previous consolidated fiscal year. Impairment losses in the previous consolidated fiscal year were ¥293 million, all on equities. No impairment losses were recorded during the cumulative first quarter of the current consolidated fiscal year.」

    Valuation gains on other securities declined from the previous fiscal year-end, but no impairment losses were recorded during the cumulative first quarter.
  24. FY2019MaterialisedAnnual report

    「At the end of the current consolidated fiscal year, the net valuation gain on “other securities” was ¥68.4 billion, a decrease of ¥2.7 billion from the end of the previous consolidated fiscal year.」

    Valuation gains on other securities declined, and impairment losses of ¥293 million on equities were also recorded during the current consolidated fiscal year.
  25. FY2019-Q3MaterialisedAnnual report

    「At the end of the third quarter of the current consolidated fiscal year, the net valuation gain on “other securities” was ¥55.0 billion, a decrease of ¥16.1 billion from the end of the previous consolidated fiscal year. No impairment losses were recorded in the previous consolidated fiscal year. Impairment losses during the cumulative third quarter were ¥314 million, all on equities.」

    Valuation gains on other securities declined significantly from the previous fiscal year-end, and impairment losses of ¥314 million, mainly on equities, were recorded during the cumulative third quarter.
  26. FY2019-Q2MitigatedAnnual report

    「At the end of the interim consolidated accounting period, the net valuation gain on “other securities” was ¥78.0 billion, an increase of ¥6.8 billion from the end of the previous consolidated fiscal year. No impairment losses were recorded in the previous consolidated fiscal year or the current interim consolidated accounting period.」

    Unrealized gains on other securities increased from the end of the previous fiscal year, and there were no impairment charges on securities during the previous fiscal year or the current interim period.
  27. FY2019-Q1MitigatedAnnual report

    「Net unrealized gains on other securities at the end of the current first quarter consolidated accounting period (30 June 2018) increased by ¥5.1 billion from the end of the previous consolidated fiscal year to ¥76.3 billion. There were no impairment charges during the previous consolidated fiscal year or the nine months ended the current first quarter.」

    Valuation gains on other securities increased from the previous fiscal year-end, and no impairment losses were recorded during the current fiscal year or the cumulative first quarter.
  28. FY2018MitigatedAnnual report

    「Net unrealized gains on other securities at the end of the current consolidated fiscal year increased by ¥700 million from the end of the previous consolidated fiscal year to ¥71.2 billion.」

    Unrealized gains on other securities increased from the end of the previous fiscal year, and there were no impairment charges on securities during the current consolidated fiscal year.
  29. FY2018-Q3MitigatedAnnual report

    「Net unrealized gains on other securities at the end of the current third quarter consolidated accounting period increased by ¥22.4 billion from the end of the previous consolidated fiscal year to ¥92.9 billion. There were no impairment charges during the previous consolidated fiscal year or the nine months ended the current third quarter.」

    Unrealized gains on other securities increased from the end of the previous fiscal year, and there were no impairment charges on securities during the current fiscal year or the nine months ended the current third quarter.
  30. FY2018-Q2MitigatedAnnual report

    「Net unrealized gains on other securities at the end of the current second quarter consolidated accounting period increased by ¥13.1 billion from the end of the previous consolidated fiscal year to ¥83.6 billion. There were no impairment charges during the previous consolidated fiscal year or the current interim consolidated accounting period.」

    Unrealized gains on other securities increased from the end of the previous fiscal year, and there were no impairment charges on securities during the previous fiscal year or the current interim period.
  31. FY2018-Q1MitigatedAnnual report

    「Net unrealized gains on other securities at the end of the current first quarter consolidated accounting period increased by ¥9.5 billion from the end of the previous consolidated fiscal year to ¥79.9 billion.」

    Unrealized gains on other securities increased from the end of the previous fiscal year. There were also no impairment charges during the previous consolidated fiscal year or the current first quarter cumulative period.
  32. FY2017WorsenedAnnual report

    「Net unrealized gains on other securities at the end of the current consolidated fiscal year decreased by ¥7.6 billion from the end of the previous consolidated fiscal year to ¥70.4 billion.」

    The increase as of the end of the third quarter turned into a decrease by the end of the full fiscal year compared with the end of the previous consolidated fiscal year. There were no impairment charges on securities.
  33. FY2017-Q3MitigatedAnnual report

    「Net unrealized gains on other securities at the end of the current third quarter consolidated accounting period increased by ¥1.4 billion from the end of the previous consolidated fiscal year to ¥79.6 billion.」

    Unrealized gains on other securities increased from the end of the previous consolidated fiscal year, and there were no impairment charges on securities during the nine months ended the current third quarter.
  34. FY2017-Q2WorsenedAnnual report

    「Net unrealized gains on other securities at the end of the current second quarter consolidated accounting period decreased by ¥12.3 billion from the end of the previous consolidated fiscal year to ¥65.7 billion.」

    Unrealized gains on other securities declined further from the end of the previous consolidated fiscal year. There were no impairment charges on securities during the current interim consolidated accounting period.
  35. FY2017-Q1First statedAnnual report

    「Net unrealized gains on other securities at the end of the current first quarter consolidated accounting period decreased by ¥8.4 billion from the end of the previous consolidated fiscal year to ¥69.7 billion.」

    Unrealized gains on other securities declined, and the company also disclosed that it recorded ¥21 million in impairment charges during the quarter.
Moved together

"Balance of risk-monitored loans" moved the same way as this thread, in the same document, in 15 of its 35 moves.

151410997★123456
  1. ★This thread
  2. 1Balance of risk-monitored loans15×
  3. 2Guarantees for privately placed corporate bonds14×
  4. 3Decline in Ordinary Income and Quarterly Net Income Attributable to Owners of the Parent10×
  5. 4Securing interest income through securities portfolio management and portfolio responses9×
  6. 5Impairment losses on fixed assets due to declining land prices and other factors9×
  7. 6Undrawn loan commitments and commitment lines7×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for The Hyakujushi Bank yet. It last moved in the Earnings of 2026-05-12: "Materialised".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Decline in valuation gains on securities and impairment losses | The Hyakujushi Bank,Ltd. (8386) | Komori